MMI Molecular Machines and Industries AG
MMI Vision: To be the preferred provider for micromanipulation solutions. With
their worldwide established distributor network, MMI is in a position to bring
innovative cell finding and sorting systems to the market. In fact, MMI installed
over 350 micromanipulation systems worldwide with a quality growth of more than
20% over the last 5 years. MMI is is not only specialized in hardware related
software development, image analysis and optical and mechanical development.
MMI systems for ultra precise preparation of biological samples from tissue,
cell cultures or cell suspensions have been established on the world market
for years. Life and material science related target markets for MMI technologies
are mainly molcular pathology, drug discovery, medical diagnostics, food and
environmental analytics.
MMI was founded in 1998 by Prof. Dr. Stefan Seeger from University of Zurich,
Switzerland. Today the company is located in Zurich/Switzerland, Munich/Germany
and Haslett/USA.
MMI is privately held. Hannover Finance, one of the biggest European Investment
Groups, is MMI’s financing partner.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.